Literature DB >> 6170307

Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug.

B A Kamen, P A Nylen, B M Camitta, J R Bertino.   

Abstract

Methotrexate has been associated with chronic toxicities such as cirrhosis and neurological impairments ranging from mild learning disorders to a fatal leucoencephalopathy. The mechanism(s) for this toxicity is not completely understood. Certain tissues can convert methotrexate to polyglutamates. This results in a more persistent intracellular form of the drug. In this study the intracellular levels of folate and methotrexate were measured in the erythrocytes and liver of patients treated chronically with methotrexate. These tissues showed an accumulation of methotrexate as polyglutamates and a concomitant loss of folate. Folate concentrations were below normal in nine of 12 red cell and three of five liver samples. It is proposed that persistent methotrexate concentrations and/or the associated folate deficiency may be related to the toxicity of methotrexate, especially in time of cellular stress.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170307     DOI: 10.1111/j.1365-2141.1981.tb07237.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  24 in total

1.  Low-dose methotrexate therapy for hepatoblastoma.

Authors:  S D Weitman; G J Kato; J L Barbosa; B A Kamen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings.

Authors:  M J Ahern; S Kevat; W Hill; P J Hayball; H Harley; P D Hall
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

3.  Pharmacokinetics of methotrexate in erythrocytes in psoriasis.

Authors:  J Hendel; A Nyfors
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Methotrexate metabolism.

Authors:  G R Krakower; B A Kamen
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Wanda L Salzer; Naomi J Winick; Pierre Wacker; Xiaomin Lu; Meenakshi Devidas; Jonathan J Shuster; Donald H Mahoney; Stephen J Lauer; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2012-01       Impact factor: 1.289

Review 6.  Hepatotoxicity of methotrexate in rheumatic diseases.

Authors:  S Kevat; M Ahern; P Hall
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

7.  Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis.

Authors:  Nemat Ali; Summya Rashid; Sana Nafees; Syed Kazim Hasan; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2013-10-24       Impact factor: 3.396

8.  Acute folic acid deficiency after bone marrow transplantation.

Authors:  H Link; M Blaurock; P Wernet; D Niethammer; K Wilms; P Ostendorf
Journal:  Klin Wochenschr       Date:  1986-05-02

9.  Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome.

Authors:  Diane C Cabelof; Hiral V Patel; Qing Chen; Holly van Remmen; Larry H Matherly; Yubin Ge; Jeffrey W Taub
Journal:  Blood       Date:  2009-07-24       Impact factor: 22.113

10.  Methotrexate pharmacokinetics in age-fractionated erythrocytes.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.